Factors released from cholestatic rat livers possibly involved in inducing bone marrow hepatic stem cell priming

Stem Cells and Development

Volumn 17, Issue 1, 2008, Pages 143-155

  Xu, Jun ^a   Deng, Xutao ^a,d   Demetriou, Achilles A ^b,c,d   Farkas, Daniel L ^b   Hui, Thomas ^b   Wang, Charles ^a,d  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CXCL1 CHEMOKINE; GELATINASE A; GROWTH ARREST SPECIFIC PROTEIN 6; GROWTH FACTOR; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 23; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOPONTIN; PROTEIN DMBT1; PROTEIN EFNA1; PROTEIN GRN; PROTEIN LEP; PROTEIN LGALS1; PROTEIN PF4; PROTEIN PMP2; PROTEIN TGFB; PROTEIN TGFB3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; INTRAHEPATIC CHOLESTASIS; LIVER CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; TRANSCRIPTOMICS;

ANIMALS; BONE MARROW; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMOKINES; CHOLESTASIS; CYTOKINES; GENE EXPRESSION PROFILING; HEPATOCYTES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; RATS; STEM CELLS; UP-REGULATION;

RATTUS;

EID: 39449122168     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2007.0094     Document Type: Article

References (109)

1. Khanna A, A Jain, B Eghtesad and J Rakela. (1999). Liver transplantation for metabolic liver diseases. Surg Clin North Am 79:153-162.
2. Dodson SF, S Issa and A Bonham. (1999). Liver transplantation for chronic viral hepatitis. Surg Clin North Am 79:131-145.
3. Hui T, J Rozga and AA Demetriou. (2001). Bioartificial liver support. J Hepatobiliary Pancreat Surg 8:1-15.
4. Rozga J and AA Demetriou. (1995). Artificial liver. Evolution and future perspectives. ASAIO J 41:831-837.
5. Moscioni AD, J Rozga, S Chen, A Naim, HS Scott and AA Demetriou. (1996). Long-term correction of albumin levels in the Nagase analbuminemic rat: repopulation of the liver by transplanted normal hepatocytes under a regeneration response. Cell Transplant 5:499-503.
6. Horslen SP, TC McCowan, TC Goertzen, PI Warkentin, HB Cai, SC Strom and IJ Fox. (2003). Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 111:1262-1267.
7. Ambrosino G, S Varotto, SC Strom, G Guariso, E Franchin, D Miotto, L Caenazzo, S Basso, P Carraro and ML Valente. (2005). Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1. Cell Transplant 14:151-157.
8. Horslen SP and IJ Fox. (2004). Hepatocyte transplantation. Transplantation 77:1481-1486.
9. Petersen BE, WC Bowen, KD Patrene, WM Mars, AK Sullivan, N Murase, SS Boggs, JS Greenberger and JP Goff. (1999). Bone marrow as a potential source of hepatic oval cells. Science 284:1168-1170.
10. Theise ND, M Nimmakayalu, R Gardner, PB Illei, G Morgan, L Teperman, O Henegariu and DS Krause. (2000). Liver from bone marrow in humans. Hepatology 32:11-16.
11. Avital I, D Inderbitzin, T Aoki, DB Tyan, AH Cohen, C Ferraresso, J Rozga, WS Arnaout and AA Demetriou. (2001). Isolation, characterization, and transplantation of bone marrow-derived hepatocyte stem cells. Biochem Biophys Res Commun 288:156-164.
12. Avital I, C Feraresso, T Aoki, T Hui, J Rozga, AA Demetriou and M Muraca. (2002). Bone marrow-derived liver stem cell and mature hepatocyte engraftment in livers undergoing rejection. Surgery 132:384-390.
13. Wang C, MR Chelly, N Chai, Y Tan, T Hui, H Li, DL Farkas and AA Demetriou. (2005). Transcriptomic fingerprinting of bone marrow-derived hepatic beta2m-/Thy-1+ stem cells. Biochem Biophys Res Commun 327:252-260.
14. Khatri P, S Draghici, GC Ostermeier and SA Krawetz. (2002). Profiling gene expression using onto-express. Genomics 79:266-270.
15. Khatri P, P Bhavsar, G Bawa and S Draghici. (2004). Onto-Tools: an ensemble of web-accessible, ontology-based tools for the functional design and interpretation of high-throughput gene expression experiments. Nucleic Acids Res 32:W449-W456.
16. Bjersing JL, A Brorsson and O Heby. (1997). Increased expression of c-jun, but not retinoic acid receptor beta, is associated with F9 teratocarcinoma stem cell differentiation induced by polyamine depletion. J Cell Biochem 67:378-385.
17. Li D, S Yea, S Li, Z Chen, G Narla, M Banck, J Laborda, S Tan, JM Friedman, SL Friedman and MJ Walsh. (2005). Kruppel-like factor-6 promotes preadipocyte differentiation through histone deacetylase 3-dependent repression of DLK1. J Biol Chem 280:26941-26952.
18. Li Y, J McClintick, L Zhong, HJ Edenberg, MC Yoder and RJ Chan. (2005). Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood 105:635-637.
19. Matsumoto N, A Kubo, H Liu, K Akita, F Laub, F Ramirez, G Keller and SL Friedman. (2006). Developmental regulation of yolk sac hematopoiesis by Kruppel-like factor 6. Blood 107:1357-1365.
20. Friedman WJ, N Altiok, BB Fredholm and H Persson. (1992). Mechanisms of nerve growth factor mRNA regulation by interleukin-1 beta in hippocampal cultures: role of second messengers. J Neurosci Res 33:37-46.
21. Yokota H, MB Goldring and HB Sun. (2003). CITED2-mediated regulation of MMP-1 and MMP-13 in human chondrocytes under flow shear. J Biol Chem 278:47275-47280.
22. Diakos C, EE Prieschl, M Saemann, V Novotny, G Bohmig, R Csonga, T Baumruker and GJ Zlabinger. (2002). Novel mode of interference with nuclear factor of activated T-cells regulation in T-cells by the bacterial metabolite n-butyrate. J Biol Chem 277:24243-24251.
23. Jurchott K, S Bergmann, U Stein, W Walther, M Janz, I Manni, G Piaggio, E Fietze, M Dietel and HD Royer. (2003). YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression. J Biol Chem 278:27988-27996.
24. Welham MJ, H Bone, M Levings, L Learmonth, LM Wang, KB Leslie, JH Pierce and JW Schrader. (1997). Insulin receptor substrate-2 is the major 170-kDa protein phosphorylated on tyrosine in response to cytokines in murine lymphohemopoietic cells. J Biol Chem 272:1377-1381.
25. Xiong H, C Zhu, H Li, F Chen, L Mayer, K Ozato, JC Unkeless and SE Plevy. (2003). Complex formation of the interferon (IFN) consensus sequence-binding protein with IRF-1 is essential for murine macrophage IFN-gamma-induced iNOS gene expression. J Biol Chem 278:2271-2277.
26. Perrin GQ, HM Johnson and PS Subramaniam. (1999). Mechanism of interleukin-10 inhibition of T-helper cell activation by superantigen at the level of the cell cycle. Blood 93:208-216.
27. Zhu C, K Rao, H Xiong, K Gagnidze, F Li, C Horvath and S Plevy. (2003). Activation of the murine interleukin-12 p40 promoter by functional interactions between NFAT and ICSBP. J Biol Chem 278:39372-39382.
28. Bamji SX, M Majdan, CD Pozniak, DJ Belliveau, R Aloyz, J Kohn, CG Causing and FD Miller. (1998). The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. J Cell Biol 140:911-923.
29. Courtney MJ, KE Akerman and ET Coffey. (1997). Neurotrophins protect cultured cerebellar granule neurons against the early phase of cell death by a two-component mechanism. J Neurosci 17:4201-4211.
30. Satoh J and Y Kuroda. (2002). The constitutive and inducible expression of Nurr1, a key regulator of dopaminergic neuronal differentiation, in human neural and nonneural cell lines. Neuropathology 22:219-232.
31. Chalaux E, T Lopez-Rovira, JL Rosa, R Bartrons and F Ventura. (1998). JunB is involved in the inhibition of myogenic differentiation by bone morphogenetic protein-2. J Biol Chem 273:537-543.
32. King KE, VP Iyemere, PL Weissberg and CM Shanahan. (2003). Kruppel-like factor 4 (KLF4/GKLF) is a target of bone morphogenetic proteins and transforming growth factor beta 1 in the regulation of vascular smooth muscle cell phenotype. J Biol Chem 278:11661-11669.
33. Lai CF and SL Cheng. (2002). Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells. J Biol Chem 277:15514-15522.
34. Shimizu T and K Takeda. (2000). Induction of retinoic acid receptor-alpha by granulocyte macrophage colony-stimulating factor in human myeloid leukemia cell lines. Cancer Res 60:4544-4549.
35. Takeda M, N Dohmae, K Takio, K Arai and S Watanabe. (2001). Cell cycle-dependent interaction of Mad2 with conserved Box1/2 region of human granulocyte-macrophage colony-stimulating factor receptor common betac. J Biol Chem 276:41803-41809.
36. Varnum BC, RW Lim, DA Kujubu, SJ Luner, SE Kaufman, JS Greenberger, JC Gasson and HR Herschman. (1989). Granulocyte-macrophage colony-stimulating factor and tetradecanoyl phorbol acetate induce a distinct, restricted subset of primary-response TIS genes in both proliferating and terminally differentiated myeloid cells. Mol Cell Biol 9:3580-3583.
37. Evans MJ, HA Harris, CP Miller, SK Karathanasis and SJ Adelman. (2002). Estrogen receptors alpha and beta have similar activities in multiple endothelial cell pathways. Endocrinology 143:3785-3795.
38. Fei J, C Viedt, U Soto, C Elsing, L Jahn and J Kreuzer. (2000). Endothelin-1 and smooth muscle cells: induction of jun amino-terminal kinase through an oxygen radicalsensitive mechanism. Arterioscler Thromb Vasc Biol 20:1244-1249.
39. Hercule HC and AO Oyekan. (2000). Role of NO and cytochrome P-450-derived eicosanoids in ET-1-induced changes in intrarenal hemodynamics in rats. Am J Physiol Regul Integr Comp Physiol 279:R2132-R2141.
40. Mu X and C Chang. (2003). TR3 orphan nuclear receptor mediates apoptosis through up-regulating E2F1 in human prostate cancer LNCaP cells. J Biol Chem 278:42840-42845.
41. Dunn SE, JV Torres, JS Oh, DM Cykert and JC Barrett. (2001). Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase. Cancer Res 61:1367-1374.
42. Bode AM, WY Ma, YJ Surh and Z Dong. (2001). Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol. Cancer Res 61:850-853.
43. Talukder AH, HF Jorgensen, M Mandal, SK Mishra, RK Vadlamudi, BF Clark, J Mendelsohn and R Kumar. (2001). Regulation of elongation factor-1alpha expression by growth factors and anti-receptor blocking antibodies. J Biol Chem 276:5636-5642.
44. Finlay GA, VJ Thannickal, BL Fanburg and KE Paulson. (2000). Transforming growth factor-beta 1-induced activation of the ERK pathway/activator protein-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor. J Biol Chem 275:27650-27656.
45. Mohan R, J Sivak, P Ashton, LA Russo, BQ Pham, N Kasahara, MB Raizman and ME Fini. (2000). Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem 275:10405-10412.
46. Lim RW, CY Zhu and B Stringer. (1995). Differential regulation of primary response gene expression in skeletal muscle cells through multiple signal transduction pathways. Biochim Biophys Acta 1266:91-100.
47. Satyamoorthy K, G Li, B Vaidya, J Kalabis and M Herlyn. (2002). Insulin-like growth factor-I-induced migration of melanoma cells is mediated by interleukin-8 induction. Cell Growth Differ 13:87-93.
48. Krause D, A Lyons, C Fennelly and R O'Connor. (2001). Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor I receptor can be suppressed by dicumarol. J Biol Chem 276:19244-19252.
49. Inishi Y, T Katoh, T Okuda, T Yamaguchi and K Kurokawa. (1997). Modulation of renal hemodynamics by IGF-1 is absent in spontaneously hypertensive rats. Kidney Int 52:165-170.
50. Stocco CO, LF Lau and G Gibori. (2002). A calcium/ calmodulin-dependent activation of ERK1/2 mediates JunD phosphorylation and induction of nur77 and 20alpha-hsd genes by prostaglandin F2alpha in ovarian cells. J Biol Chem 277:3293-3302.
51. Chen DB, SD Westfall, HW Fong, MS Roberson and JS Davis. (1998). tProstaglandin F2alpha stimulates the Raf/MEK1/mitogen-activated protein kinase signaling cascade in bovine luteal cells. Endocrinology 139:3876-3885.
52. Adam PJ, CP Regan, MB Hautmann and GK Owens. (2000). Positive- and negative-acting Kruppel-like transcription factors bind a transforming growth factor beta control element required for expression of the smooth muscle cell differentiation marker SM22alpha in vivo. J Biol Chem 275:37798-37806.
53. Coussens LM, K Yokoyama and R Chiu. (1994). Transforming growth factor beta 1-mediated induction of junB is selectively inhibited by expression of Ad.12-E1A. J Cell Physiol 160:435-444.
54. Miller MJ, A Martinez, EJ Unsworth, CJ Thiele, TW Moody, T Elsasser and F Cuttitta. (1996). Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor. J Biol Chem 271:23345-23351.
55. Sato A and DJ Autelitano. (1995). Adrenomedullin induces expression of c-fos and AP-1 activity in rat vascular smooth muscle cells and cardiomyocytes. Biochem Biophys Res Commun 217:211-216.
56. Hirata Y, H Hayakawa, Y Suzuki, E Suzuki, H Ikenouchi, O Kohmoto, K Kimura, K Kitamura, T Eto and K Kangawa. (1995). Mechanisms of adrenomedullin-induced vasodilation in the rat kidney. Hypertension 25:790-795.
57. Tetradis S, O Bezouglaia, A Tsingotjidou and A Vila. (2001). Regulation of the nuclear orphan receptor Nur77 in bone by parathyroid hormone. Biochem Biophys Res Commun 281:913-916.
58. Hollnagel A, D Schroder and G Gross. (1996). Domain-specific gene activation by parathyroid hormone in osteoblastic ROS17/2.8 cells. J Biol Chem 271:21870-21877.
59. Evans CA, S Ariffin, A Pierce and AD Whetton. (2002). Identification of primary structural features that define the differential actions of IL-3 and GM-CSF receptors. Blood 100:3164-3174.
60. Inderbitzin D, I Avital, A Keogh, G Beldi, M Quarta, B Gloor and D Candinas. (2005). Interleukin-3 induces hepatocyte-specific metabolic activity in bone marrow-derived liver stem cells. J Gastrointest Surg 9:69-74.
61. McKinstry WJ, CL Li, JE Rasko, NA Nicola, GR Johnson and D Metcalf. (1997). Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood 89:65-71.
62. Dalakas E, PN Newsome, DJ Harrison and JN Plevris. (2005). Hematopoietic stem cell trafficking in liver injury. FASEB J 19:1225-1231.
63. Michalopoulos GK and MC DeFrances. (1997). Liver regeneration. Science 276:60-66.
64. Alison MR, R Poulsom and SJ Forbes. (2001). Update on hepatic stem cells. Liver 21:367-373.
65. Sell S. (2001). Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology 33:738-750.
66. Sell S. (2001). The role of progenitor cells in repair of liver injury and in liver transplantation. Wound Repair Regen 9:467-482.
67. Petersen BE, VF Zajac and GK Michalopoulos. (1998). Hepatic oval cell activation in response to injury following chemically induced periportal or pericentral damage in rats. Hepatology 27:1030-1038.
68. Thorgeirsson SS, RP Evarts, HC Bisgaard, K Fujio and Z Hu. (1993). Hepatic stem cell compartment: activation and lineage commitment. Proc Soc Exp Biol Med 204:253-260.
69. Lagasse E, H Connors, M Al Dhalimy, M Reitsma, M Dohse, L Osborne, X Wang, M Finegold, IL Weissman and M Grompe. (2000). Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nature Med 6:1229-1234.
70. Bajetto A, R Bonavia, S Barbero, P Piccioli, A Costa, T Florio and G Schettini. (1999). Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J Neurochem 73:2348-2357.
71. Yang SR, SD Cho, NS Ahn, JW Jung, JS Park, EH Jo, JW Hwang, SH Kim, BH Lee, KS Kang and YS Lee. (2005). The role of p38 MAP kinase and c-Jun N-terminal protein kinase signaling in the differentiation and apoptosis of immortalized neural stem cells. Mutat Res 579:47-57.
72. Tamura T, P Thotakura, TS Tanaka, MS Ko and K Ozato. (2005). Identification of target genes and a unique cis element regulated by IRF-8 in developing macrophages. Blood 106:1938-1947.
73. Tamura T and K Ozato. (2002). ICSBP/IRF-8: its regulatory roles in the development of myeloid cells. J Interferon Cytokine Res 22:145-152.
74. Jankovic V, A Ciarrocchi, P Boccuni, T DeBlasio, R Benezra and SD Nimer. (2007). Id1 restrains myeloid commitment, maintaining the self-renewal capacity of hematopoietic stem cells. Proc Natl Acad Sci USA 104:1260-1265.
75. Burdon T, A Smith and P Savatier. (2002). Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol 12:432-438.
76. Chadwick K, L Wang, L Li, P Menendez, B Murdoch, A Rouleau and M Bhatia. (2003). Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 102:906-915.
77. Chambers I and A Smith. (2004). Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 23:7150-7160.
78. Kristensen DM, M Kalisz and JH Nielsen. (2005). Cytokine signalling in embryonic stem cells. APMIS 113:756-772.
79. Zandstra PW, E Conneally, AL Petzer, JM Piret and CJ Eaves. (1997). Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci USA 94:4698-4703.
80. Zandstra PW, HV Le, GQ Daley, LG Griffith and DA Lauffenburger. (2000). Leukemia inhibitory factor (LIF) concentration modulates embryonic stem cell self-renewal and differentiation independently of proliferation. Biotechnol Bioeng 69:607-617.
81. Finotto S, J Siebler, M Hausding, M Schipp, S Wirtz, S Klein, M Protschka, A Doganci, HA Lehr, C Trautwein, R Khosravi-Far, D Strand, A Lohse, PR Galle, M Blessing and MF Neurath. (2004). Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo. Gut 53:392-400.
82. Knight B, VB Matthews, B Akhurst, EJ Croager, E Klinken, LJ Abraham, JK Olynyk and G Yeoh. (2005). Liver inflammation and cytokine production, but not acute phase protein synthesis, accompany the adult liver progenitor (oval) cell response to chronic liver injury. Immunol Cell Biol 83:364-374.
83. Tsutsui H, K Matsui, N Kawada, Y Hyodo, N Hayashi, H Okamura, K Higashino and K Nakanishi. (1997). IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J Immunol 159:3961-3967.
84. Kim CH and HE Broxmeyer. (1998). In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood 91:100-110.
85. Lapidot T and O Kollet. (2002). The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice. Leukemia 16:1992-2003.
86. Petit I, M Szyper-Kravitz, A Nagler, M Lahav, A Peled, L Habler, T Ponomaryov, RS Taichman, F renzana-Seisdedos, N Fujii, J Sandbank, D Zipori and T Lapidot. (2002). G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nature Immunol 3:687-694.
87. Kollet O, S Shivtiel, YQ Chen, J Suriawinata, SN Thung, MD Dabeva, J Kahn, A Spiegel, A Dar, S Samira, P Gorchberg, A Kalinkovich, Frenzana-Seisdedos, A Nagler, I Hardan, M Revel, DA Shafritz and T Lapidot. (2003). HGF, SDF-1, and MMP-9 are involved in stressinduced human CD34+ stem cell recruitment to the liver. J Clin Invest 112:160-169.
88. Bleul CC, RC Fuhlbrigge, JM Casasnovas, A Aiuti and TA Springer. (1996). A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 184:1101-1109.
89. Kim CH, LM Pelus, JR White and HE Broxmeyer. (1998). Differential chemotactic behavior of developing T cells in response to thymic chemokines. Blood 91:4434-4443.
90. Goddard S, A Williams, C Morland, S Qin, R Gladue, SG Hubscher and DH Adams. (2001). Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants. Transplantation 72:1957-1967.
91. Hatch HM, D Zheng, ML Jorgensen and BE Petersen. (2002). SDF-1alpha/CXCR4: a mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats. Cloning Stem Cells 4:339-351.
92. Terada R, K Yamamoto, T Hakoda, N Shimada, N Okano, N Baba, Y Ninomiya, ME Gershwin and Y Shiratori. (2003). Stromal cell-derived factor-1 from biliary epithelial cells recruits CXCR4-positive cells: implications for inflammatory liver diseases. Lab Invest 83:665-672.
93. Wang L, Y Li, J Chen, SC Gautam, Z Zhang, M Lu and M Chopp. (2002). Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture. Exp Hematol 30:831-836.
94. Aiuti A, IJ Webb, C Bleul, T Springer and JC Gutierrez-Ramos. (1997). The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 185:111-120.
95. Heissig B, K Hattori, S Dias, M Friedrich, B Ferris, NR Hackett, RG Crystal, P Besmer, D Lyden, MA Moore, Z Werb and S Rafii. (2002). Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109:625-637.
96. Janowska-Wieczorek A, LA Marquez, A Dobrowsky, MZ Ratajczak and ML Cabuhat. (2000). Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines. Exp Hematol 28:1274-1285.
97. Haruyama T, I Ajioka, T Akaike and Y Watanabe. (2000). Regulation and significance of hepatocyte-derived matrix metalloproteinases in liver remodeling. Biochem Biophys Res Commun 272:681-686.
98. Kuyvenhoven JP, HW Verspaget, Q Gao, J Ringers, VT Smit, CB Lamers and B van Hoek. (2004). Assessment of serum matrix metalloproteinases MMP-2 and MMP-9 after human liver transplantation: increased serum MMP-9 level in acute rejection. Transplantation 77:1646-1652.
99. Lichtinghagen R, MJ Bahr, M Wehmeier, D Michels, CI Haberkorn, B Arndt, P, Flemming MP Manns and KH Boeker. (2003). Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis. Clin Sci (Lond) 105:373-382.
100. Lijnen HR. (2001). Elements of the fibrinolytic system. Ann N Y Acad Sci 936:226-236.
101. Lijnen HR. (2001). Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost 86:324-333.
102. Lo EH, X Wang and ML Cuzner. (2002). Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J Neurosci Res 69:1-9.
103. Mignatti P and DB Rifkin. (1996). Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 49:117-137.
104. Nilsson SK, HM Johnston, GA Whitty, B Williams, RJ Webb, DT Denhardt, I Bertoncello, LJ Bendall, PJ Simmons and DN Haylock. (2005). Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 106:1232-1239.
105. Stier S, Y Ko, R Forkert, C Lutz, T Neuhaus, E Grunewald, T Cheng, D Dombkowski, LM Calvi, SR Rittling and DT Scadden. (2005). Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med 201:1781-1791.
106. Wilson A and A Trumpp. (2006). Bone-marrow haematopoietic-stem-cell niches. Nature Rev Immunol 6:93-106.
107. Arai M, O Yokosuka, K Fukai, F Imazeki, T Chiba, H Sumi, M Kato, M Takiguchi, H Saisho, M Muramatsu and N Seki. (2004). Gene expression profiles in liver regeneration with oval cell induction. Biochem Biophys Res Commun 317:370-376.
108. Arai M, O Yokosuka, T Kanda, K Fukai, F Imazeki, M Muramatsu, N Seki, M Miyazaki, T Ochiai, H Hirasawa and H Saisho. (2006). Serum osteopontin levels in patients with acute liver dysfunction. Scand J Gastroenterol 41:102-110.
109. Zimmermann A. (2002). Liver regeneration: the emergence of new pathways. Med Sci Monit 8:RA53-RA63.